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Abstract
In a previous study, we demonstrated that parathyroid hormone (PTH) stimulates in rat duodenal cells (enterocytes) the
phosphorylation and activity of extracellular signal-regulated mitogen-activated protein kinase (MAPK) isoforms ERK1 and
ERK2. As PTH activates adenylyl cyclase (AC) and phospholipase C and increases intracellular Ca2 in these cells, in the
present study we evaluated the involvement of cAMP, Ca2 and protein kinase C (PKC) on PTH-induced MAPK activation.
We found that MAPK phosphorylation by the hormone did not depend on PKC activation. PTH response could, however,
be mimicked by addition of forskolin (5^15 WM), an AC activator, or Sp-cAMP (50^100 WM), a cAMP agonist, and
suppressed to a great extent by the AC inhibitor, compound Sq-22536 (0.2^0.4 mM) and the cAMP antagonist Rp-cAMP
(0.2 mM). Removal of external Ca2 (EGTA 0.5 mM), chelation of intracellular Ca2 with BAPTA (5 WM), or blockade of
L-type Ca2-channels with verapamil (10 WM) significantly decreased PTH-activation of MAPK. Furthermore, a similar
degree of phosphorylation of MAPK was elicited by the Ca2 mobilizing agent thapsigargin, the Ca2 ionophore A23187,
ionomycin and membrane depolarization with high K. Inclusion of the calmodulin inhibitor fluphenazine (50 WM) did not
prevent hormone effects on MAPK. Taken together, these results indicate that cAMP and Ca2 play a role upstream in the
signaling mechanism leading to MAPK activation by PTH in rat enterocytes. As Ca2 and cAMP antagonists did not block
totally PTH-induced MAPK phosphorylation, it is possible that linking of the hormone signal to the MAPK pathway may
additionally involve Src, which has been previously shown to be rapidly activated by PTH. Of physiological significance, in
agreement with the mitogenic role of the MAPK cascade, PTH increased enterocyte DNA synthesis, and this effect was
blocked by the specific inhibitor of MAPK kinase (MEK) PD098059, indicating that hormone modulation of MAPK
through these messenger systems stimulates duodenal cell proliferation. ß 2001 Elsevier Science B.V. All rights re-
served.
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1. Introduction
Parathyroid hormone (PTH), a peptide composed
of 84 amino acids, is the main secreted and circulat-
ing form of bioactive PTH [1] and is responsible for
the regulation of calcium levels in blood and extra-
cellular £uids in concert with other calciotropic hor-
mones [2]. PTH and its analog the parathyroid-re-
lated protein (PTHrP) [3] bind to a common
membrane receptor. Expression of the PTH/PTHrP
receptor was observed in the classical target tissues,
bone and kidney, but was also found in many
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other tissues [4], including the gastrointestinal tract
[5,6].
The transduction of PTH signal through the plas-
ma membrane of target tissues involves both a
Gs-mediated stimulation of adenylyl cyclase (AC)
with cAMP production [7] and a Gq-mediated acti-
vation of phospholipase CL, leading to generation of
inositol 1,4,5-trisphosphate (IP3) and diacylglycerol
(DAG) [8]. After second messenger formation,
cAMP activates protein kinase A [9], IP3 releases
calcium from intracellular stores [10] and DAG
causes translocation of protein kinase C from the
cytosol to the cell membrane [11].
Although the intestine is not considered a classical
target tissue for PTH, we have demonstrated direct
e¡ects of parathyroid hormone in duodenal cells, in-
volving G protein-coupled stimulation of AC and
PLC and activation of PKA and PKC which in
turn regulate Ca2 in£ux through voltage-dependent
Ca2 channels [12,13]. PTH also increases intracellu-
lar Ca2 levels by promoting an initial acute IP3-
mediated mobilization of Ca2 from inner stores
([13]; G. Picotto, submitted). The identity of down-
stream e¡ectors and their role in cellular responses to
PTH/PTHrP are unclear. We have recently shown
that in rat enterocytes, PTH rapidly and in a dose-
dependent fashion stimulates tyrosine phosphoryla-
tion of several enterocyte proteins [14], among which
one of the major targets of the hormone could be
immunochemically identi¢ed as the growth-related
protein mitogen-activated protein (MAP) kinases
(p42/44-MAPK), also known as extracellular signal-
regulated kinases (ERK1/2) [15]. Moreover, initial
studies on the mechanisms underlying PTH activa-
tion of the enterocytes MAPK cascade revealed that
the hormone stimulates Src tyrosine kinase activity
and consequently downstream activates the p21ras/
MAPK pathway [15]. In the present study we exam-
ined whether cAMP, PKC and Ca2 are upstream
mediators of PTH-induced MAPK phosphorylation,
i.e., its activation, in rat duodenal cells.
2. Materials and methods
2.1. Chemicals
Synthetic rat PTH (1^34), leupeptin, aprotinin,
Immobilon P (polyvinylidene di£uoride, PVDF)
membranes, forskolin, TPA (12-o-tetradecanoyl
phorbol 13-acetate), verapamil and thapsigargin
were from Sigma Chemical Co. (St. Louis, MO,
USA). Calphostin C, RO 31-820 and BAPTA/AM
(1,2-bis(o-aminophenoxy)ethane-N,N,NP,NP-tetraace-
tic acid tetra(acetoxymethyl)ester), Sp-cAMP (cyclic
adenosine 3P,5P-monophosphorothioate, Sp diaste-
reomer) and Rp-cAMP (cyclic adenosine 3P,5P-mono-
phosphorothioate, Rp diastereomer) were from Cal-
biochem (San Diego, CA, USA). Sq-22536 ((9-
(tetrahydro-2P-furyl)adenine) was a kind gift from
Dr. S.J. Lucania (Bristol Myer Squibb, NJ, USA).
Rabbit anti-active (phospho-)MAPK antibody (reac-
tive against the phosphorylated 42 and 44 kDa iso-
forms) was from Promega (Madison, WI, USA). Sec-
ondary antibody goat anti-rabbit horseradish
peroxidase-conjugated IgG and the Super Signal
CL-HRP substrate system for enhanced chemilumi-
nescence (ECL) were obtained from Amersham
Corp. (Arlington Heights, IL, USA). All other re-
agents were of analytical grade.
2.2. Animals
Male Wistar rats (3 months old) were fed with
standard rat food (1.2% Ca; 1.0% phosphorus), giv-
en water ad libitum and maintained on a 12:12-h
light/dark cycle. Animals were killed by cervical dis-
location.
2.3. Isolation of duodenal cells
Duodenal cells were isolated essentially as previ-
ously described [16]. The method employed yields
preparations that contain only highly absorptive ep-
ithelial cells and are devoid of cells from the upper
villus or crypt [17,18]. The duodenum was excised,
washed and trimmed of adhering tissue. The intestine
was slit lengthwise and cut into small segments (2 cm
length) and placed into solution A (96 mM NaCl, 1.5
mM KCl, 8 mM KH2PO4, 5.6 mM Na2HPO4, 27
mM Na citrate, pH 7.3) for 10 min at 37‡C. The
solution was discarded and replaced with solution
B (isolation medium): 154 mM NaCl, 10 mM
NaH2PO4, 1.5 mM EDTA, 0.5 mM dithiothreitol
(DTT), 5.6 mM glucose, pH 7.3, for 15 min at
37‡C with vigorous shaking. The cells were sedi-
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mented by centrifugation at 750Ug for 10 min,
washed twice with 154 mM NaCl, 10 mM NaH2PO4,
5.6 mM glucose, pH 7.4 and resuspended in the in-
cubation medium (solution C): 154 mM NaCl, 5 mM
KCl, 1 mM Na2HPO4, 1 mM MgCl2, 10 mM
NaMOPS (pH 7.4), 5.6 mM glucose, 0.5% BSA,
1 mM CaCl2. All the above steps were performed
under a 95% O2/5% CO2 atmosphere and using oxy-
genated solutions. The enterocytes were used be-
tween 20 and 60 min after their isolation. Cell via-
Fig. 1. E¡ect of calphostin C, Ro 31-820 and TPA on PTH-induced MAPK phosphorylation. Enterocytes were treated with 1038 M
PTH during 1 min in the absence or presence of (A) calphostin C (100 nM), TPA (100 nM) or (B) Ro 31-820 (200 nM). The cells
were then lysed, comparable protein aliquots were separated by SDS^PAGE followed by Western blotting with anti-active (phospho-)-
MAP kinase as described in Section 2. Total MAPK was measured in the same immunoblot by stripping the membrane and reincu-
bating with anti-total MAPK (ERK1/2). (A,B) Upper panel: representative immunoblot; lower panel : bar graphs represent intensities
of both phospho p42 and phospho p44 MAPK quanti¢ed by scanning densitometry of blots from three independent experiments.
*P6 0.025 with respect to the control (C).
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bility was assessed by trypan blue exclusion in dis-
persed cell preparations; 85^90% of the cells were
viable for at least 150 min. Phase-contrast microsco-
py of preparations revealed no morphological di¡er-
ences between enterocytes isolated from young and
old rats as in previous studies [19].
2.4. In vitro treatments
Isolated duodenal cells were pre-equilibrated in so-
lution D for 15 min and then exposed for short in-
tervals (30 s^10 min) to PTH (1038 M), agonists or
vehicle alone. After treatment, enterocytes were lysed
in 50 mM Tris^HCl (pH 7.4), 150 mM NaCl, 2 mM
EGTA, 25 mM NaF, 0.2 mM sodium orthovana-
date, 1 mM phenylmethylsulfonyl £uoride, 2 Wg/ml
leupeptin, 2 Wg/ml pepstatin, 2 Wg/ml aprotinin,
0.25% sodium deoxycholate and 1% NP40. Insoluble
material was pelleted in a microcentrifuge at 14 000
rpm for 10 min. The protein content of the clear
lysates was determined according to Lowry [20].
2.5. Sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE) and
immunoblotting
Lysate proteins dissolved in Laemmli sample bu¡-
er were separated on SDS^polyacrylamide (10%) gels
[21], and electrotransferred to polyvinylidene di£uor-
ide (PVDF) membranes. The membranes were
blocked for 1 h at room temperature in TBST (50
mM Tris^HCl (pH 7.4), 200 mM NaCl, 1% Tween
20) containing 1% dry milk). For the detection of
MAPK, membranes were subjected to immunoblot-
ting using a rabbit anti-active (phospho-)MAP ki-
nase (phosphorylated p42 and p44 isoforms). Next,
the membranes were washed three times in TBST,
incubated with a 1:10 000 dilution of peroxidase-con-
jugated anti-rabbit secondary antibody for 1 h at
room temperature and washed three additional times
with TBST. The membranes were then visualized us-
ing an enhanced chemiluminescent technique (ECL,
Amersham Corp.), according to the manufacturer’s
      u
Fig. 2. Forskolin mimics the e¡ects of PTH on MAPK phosphorylation. Enterocytes were treated with 1038 M PTH or forskolin
(5^15 WM) during 1 min, the cells were then lysed, and comparable protein aliquots were separated by SDS^PAGE followed by West-
ern blotting with anti-active (phospho-)MAP kinase as described in Section 2. Total MAPK was measured in the same immunoblot
by stripping the membrane and reincubating with anti-total MAPK (ERK1/2). Upper panel : representative immunoblot. Lower panel :
bar graphs represent intensities of both phospho p42 and phospho p44 MAPK quanti¢ed by scanning densitometry of blots from
three independent experiments. *P6 0.025, **P6 0.05, with respect to the control (C).
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instructions. Images were obtained with a model GS-
700 Imaging Densitometer from Bio-Rad (Hercules,
CA, USA) by scanning at 600 dpi and printing at the
same resolution. Bands were quanti¢ed using the
Molecular Analyst program (Bio-Rad).
2.6. Thymidine incorporation
The rate of thymidine incorporation into DNA
was determined by adding 2 WCi [3H]thymidine (20
Ci/mmol)/ml solution C to enterocytes followed by
incubation for 2 h at 37‡C under O2/CO2 (95:5%).
The cells were then centrifuged and washed four
times with solution C. DNA and proteins were pre-
cipitated with ice-cold 12% trichloroacetic acid, dis-
solved in 1 N NaOH and the radioactivity was
counted in a liquid scintillation counter.
2.7. Statistical analysis
Statistical signi¢cance of the data was evaluated
using Student’s t-test [22] and probability values be-
low 0.05 (P6 0.05) were considered signi¢cant. Re-
sults are expressed as mean þ standard deviation
(S.D.) from the indicated set of experiments.
3. Results
In the present study we examined signal transduc-
tion pathways through which parathyroid hormone
triggers MAP kinase activation in rat enterocytes. On
the grounds described below, the participation of the
PKC, adenylyl cyclase/cAMP/PKA and Ca2 mes-
senger pathways was evaluated using appropriate ag-
onists and antagonists of these signaling systems in
conjunction with the hormone. The e¡ects of PTH
were tested for 1 min using a concentration of 1038
M, conditions which elicit maximal stimulation of
MAPK as shown in previous dose^response and
time^response studies [15].
In enterocytes the hormone leads to the mobiliza-
tion of intracellular calcium via the PI-PLC pathway,
the increased Ca2 together with the PI-PLC-cata-
Fig. 3. E¡ect of the cAMP agonist Sp-cAMP on MAPK phosphorylation in rat enterocytes. Enterocytes were treated with 1038 M
PTH or Sp-cAMP (50^100 WM) during 1 min. The cells were then lysed and comparable aliquots of lysate proteins were separated by
SDS^PAGE followed by Western blotting with anti-active (phospho-)MAP kinase as described in Section 2. Total MAPK was mea-
sured in the same immunoblot by stripping the membrane and reincubating with anti-total MAPK (ERK1/2). Upper panel : represen-
tative immunoblot. Lower panel : bar graphs represent intensities of both phospho p42 and phospho p44 MAPK quanti¢ed by scan-
ning densitometry of blots from three independent experiments. *P6 0.025 with respect to the control (C).
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Fig. 4. PTH-dependent MAPK phosphorylation is suppressed by the adenylyl cyclase inhibitor Sq-22536 and the cAMP antagonist
Rp-cAMP. Enterocytes were treated with 1038 M PTH during 1 min in the absence or presence of (A) Sq-22536 (0.2^0.4 mM) or (B)
Rp-cAMP (0.2 mM). The cells were then lysed, comparable protein aliquots were separated by SDS^PAGE followed by Western blot-
ting with anti-active (phospho-)MAP kinase as described in Section 2. Total MAPK was measured in the same immunoblot by strip-
ping the membrane and reincubating with anti-total MAPK (ERK1/2). (A,B) Upper panel : representative immunoblot; lower panel :
bar graphs represent intensities of both phospho p42 and phospho p44 MAPK quanti¢ed by scanning densitometry of blots from
three independent experiments. A control is provided for each concentration of Sq-22536. *P6 0.025 with respect to the correspond-
ing control.
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lyzed elevation in DAG [13] can then activate PKC
[23]. To evaluate whether PKC is required for PTH-
induced MAP kinase stimulation, the cells were
treated with 1038 M PTH for 1 min in the presence
of the PKC inhibitors calphostin C (100 nM) or Ro
31-820 (200 nM) followed by immunoblot analysis
using an antibody speci¢c for active (phosphorylat-
ed) MAPK. As shown in Fig. 1, neither PKC inhib-
itor suppressed hormone-induced MAPK phosphor-
ylation. Short exposure (1 min) to low TPA levels
(100 nM), conditions which activate PKC, did not
increase MAPK phosphorylation (Fig. 1A).
Previous investigations have shown that PTH
markedly increases the activity of adenylyl cyclase
and cAMP levels in rat enterocytes (ca. 190% and
170%, respectively) [12,13]. We tested whether this
pathway is involved in PTH-stimulation of MAPK.
As shown in Fig. 2, forskolin, an activator of ade-
nylyl cyclase, induced MAPK phosphorylation,
although this e¡ect did not vary much among di¡er-
ent doses of the diterpene. This observation may be
tentatively explained by some resistance of the rat
duodenal adenylyl cyclase (AC), as the extent of its
stimulation by forskolin depends on the isoform
type, AC-9 being the least sensitive [24]. The e¡ects
of PTH in enterocytes were also mimicked by the
cAMP agonist Sp-cAMP (50^100 WM) (Fig. 3). To
further evaluate the participation of the cAMP path-
way in the stimulation of MAPK caused by PTH,
enterocytes were preincubated with Rp-cAMP (0.2
mM), a highly speci¢c competitive antagonist for
all activators of the cAMP signal pathway [25,26],
and with compound Sq-22536 (0.2^0.4 mM), a spe-
ci¢c inhibitor of adenylyl cyclase, followed by hor-
mone stimulation. Both, the adenylyl cyclase inhibi-
tor (Fig. 4A) and the cAMP antagonist (Fig. 4B)
suppressed, to a great extent, hormone-dependent
MAPK phosphorylation. Sq-22536 alone gave values
greater than basal in enterocytes, which may be due
to stimulation of metabolic components related to
Fig. 5. E¡ects of thapsigargin, ionophore A23187, ionomycin and high K on MAPK phosphorylation in rat enterocytes. Enterocytes
were treated with 1038 M PTH or 0.5 WM thapsigargin, 1 WM ionophore A23187, 1 WM ionomycin or 75 mM KCl during 1 min.
The cells were then lysed and comparable aliquots of lysate proteins were separated by SDS^PAGE followed by Western blotting
with anti-active (phospho-)MAP kinase as described in Section 2. Total MAPK was measured in the same immunoblot by stripping
the membrane and reincubating with anti-total MAPK (ERK1/2). (A) Representative immunoblot. (B) Bar graphs represent intensities
of both phospho p42 and phospho p44 MAPK quanti¢ed by scanning densitometry of blots from three independent experiments.
*P6 0.01 with respect to the control (C).
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the cAMP pathway, independently of its inhibitory
action on adenylyl cyclase (S.J. Lucania, Bristol
Myer Squibb, NJ, USA, personal communication).
As the function of the cyclic AMP and Ca2 sig-
naling systems are intimately linked, experiments
were carried out to investigate whether the calcium
messenger system mediates the stimulation of the
MAPK pathway by PTH in rat enterocytes. To
that end we evaluated the e¡ects on MAP kinase
phosphorylation of the intracellular Ca2 mobilizing
agent thapsigargin, compound A23187, a Ca2 ion-
ophore with an action that relies primarily on calci-
um in£ux, ionomycin and membrane depolarization
with high K. As shown in Fig. 5, a marked stim-
ulation of MAP kinase phosphorylation was ob-
served after 1 min of treatment of enterocytes with
0.5 WM thapsigargin, 1 WM A23187, 1 WM ionomycin
or 75 mM KCl. We then evaluated the e¡ects on
PTH-induced MAPK phosphorylation of the
L-type calcium channel blocker verapamil (10 WM),
EGTA (0.5 mM), an extracellular Ca2 chelator act-
ing on calcium in£ux and the intracellular calcium
chelator BAPTA (5 WM). As shown in Fig. 6, in cells
pretreated with EGTA or loaded with BAPTA,
phosphorylation of MAPK by PTH was inhibited.
The Ca2-channel blocker suppressed by 60% hor-
mone-dependent MAPK phosphorylation. Treat-
ment with EGTA alone gave values greater than
basal; this may be possibly due to the fact that
when cells are depleted from extracellular Ca2,
they liberate the cation from intracellular stores
and thus activate the MAPK cascade, explanation
sustained by the observation that thapsigargin stim-
ulates MAPK. Pretreatment with £uphenazine (50
WM), a calmodulin antagonist, did not prevent
PTH-induced activation of MAPK (Fig. 7), ruling
out the involvement of calmodulin in this process.
In view of the role of MAPK in the regulation of
cellular growth, studies were carried out to test
whether PTH exerted a mitogenic action on duode-
nal cells through the observed mechanism of stimu-
lation of MAPK. Accordingly, Fig. 8 shows that
1038 M PTH increased enterocyte DNA synthesis
by 67%, an e¡ect that was e¡ectively suppressed by
Fig. 6. The Ca2-channel blocker verapamil, EGTA and BAPTA a¡ect MAPK phosphorylation by PTH in rat enterocytes. Entero-
cytes were treated with 1038 M PTH during 1 min in the presence or absence of verapamil (10 WM), EGTA (0.5 mM) or BAPTA
(5 WM). The cells were then lysed and comparable aliquots of lysate proteins were separated by SDS^PAGE followed by Western
blotting with anti-active (phospho-)MAP kinase as described in Section 2. Total MAPK was measured in the same immunoblot by
stripping the membrane and reincubating with anti-total MAPK (ERK1/2). (A) Representative immunoblot. (B) Bar graphs represent
intensities of both phospho p42 and phospho p44 MAPK quanti¢ed by scanning densitometry of blots from three independent experi-
ments. **P6 0.01, *P6 0.025 with respect to its corresponding control.
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compound PD098059 (20 WM), which inhibits
MAPK activation by the dual MAPK kinase MEK.
4. Discussion
Mitogen-activated protein kinases are protein ser-
ine and threonine kinases that play an important role
in signal transduction mechanisms linked to the reg-
ulation of cell proliferation and di¡erentiation [27].
The MAPK cascade is stimulated shortly after extra-
cellular signals bind to receptor tyrosine kinases or
heterotrimeric G protein-coupled receptors (GPCRs)
[28]. GPCRs regulate MAPK activity, depending on
 
   
         
  
  
Fig. 7. PTH-stimulation of MAPK phosphorylation in rat enterocytes is not suppressed by £uphenazine. Enterocytes were treated
with 1038 M PTH during 1 min in the presence or absence of 50 WM £uphenazine. The cells were then lysed and comparable aliquots
of lysate proteins were separated by SDS^PAGE followed by Western blotting with anti-active (phospho-)MAP kinase as described in
Section 2. Total MAPK was measured in the same immunoblot by stripping the membrane and reincubating with anti-total MAPK
(ERK1/2). (A) Representative immunoblot. (B) Bar graphs represent intensities of both phospho p42 and phospho p44 MAPK quanti-
¢ed by scanning densitometry of blots from three independent experiments. *P6 0.01 with respect to the control (C).
Fig. 8. PTH-induced DNA synthesis in rat enterocytes is suppressed by MAPK kinase (MEK) inhibitor PD098059. Enterocytes were
incubated for 2 h with or without 1038 M PTH in the presence or absence of PD098059 (20 WM). DNA synthesis was measured by
[3H]thymidine incorporation as described in Section 2. Results are the average of three independent experiments þ s.d. **P6 0.001
with respect to the control (C).
BBAMCR 14787 21-9-01
C. Gentili et al. / Biochimica et Biophysica Acta 1540 (2001) 201^212 209
the identity of the G protein, the receptor, and the
cell type involved. MAPK activation through
Gi-coupled receptors involves the release of GLQ sub-
units [29^31], which via an as yet unidenti¢ed tyro-
sine kinase induce the phosphorylation of Shc, lead-
ing to the formation of a Shc-Grb2 complex and
activation of Ras [32]. For receptor coupled to Gq,
both LQ subunit-dependent [31] and LQ subunit-inde-
pendent [29] activation of MAPK has been reported.
The LQ subunit-induced activation is mediated by
Ras [31], whereas the GqK-induced activation is
mediated by PKC in a Ras-independent manner
[33]. Gs-coupled receptors, depending on the cell
type, can either trigger or inhibit MAPK activation
[34^36]. In addition, a number of non-receptor tyro-
sine kinases, such as Src, can be activated by various
mechanisms and feed into the MAPK pathway [37].
Src activation promotes binding to the adapter pro-
tein Grb2 [38] and complexes with the exchange fac-
tor Sos, thus providing a network for signal trans-
mission [39].
We have recently reported that PTH treatment of
rat intestinal cells stimulates the activity of the non-
receptor tyrosine kinase Src, which in turn controls
the activation of the MAPK cascade [15]. In an at-
tempt to further characterize the mechanisms in-
volved in PTH activation of the MAPK pathway in
rat enterocytes, we ¢rst investigated the involvement
of PKC. The fact that the PKC inhibitors calphostin
C and Ro 31-820 did not abolish the PTH-induced
increase in MAP kinase phosphorylation while treat-
ment with the phorbol ester TPA could not mimic
the hormone e¡ect, rules out the participation of
PKC in the action of PTH on MAPK. However,
evidence was gathered on the involvement of
cAMP/PKA in PTH activation of the MAPK path-
way. Thus, we found that stimulation of MAPK by
PTH was suppressed to a great extent by the speci¢c
inhibitor of adenylyl cyclase Sq-22536 and the cAMP
antagonist Rp-cAMP, whereas the hormone e¡ects
were mimicked by the adenylyl cyclase activator for-
skolin and the cAMP agonist Sp-cAMP. There is
evidence demonstrating that cAMP can either acti-
vate or inhibit the MAPK pathway in di¡erent cell
types, e¡ects which in most cases are reproduced by
addition of cell-permeable cAMP analogs [34^36].
With respect to the inhibition of MAPK activation,
it has been demonstrated that stimulation of cAMP-
dependent PKA interferes with Ras-mediated activa-
tion of MAPK at the level of Raf-1 [40]. However,
the mechanism behind the cAMP-dependent en-
hancement of MAPK, is largely unclear [36,41].
From recent studies with Chinese hamster ovary
and rat pheochromocytoma cells it has been pro-
posed that cAMP activates Rap1 which then stimu-
lates Raf isoform B and that cAMP-activation of
Rap1 may occur through guanine nucleotide ex-
change factors which are regulated directly by
cAMP binding or indirectly by a mechanism requir-
ing PKA phosphorylation [42,43]. Moreover, it has
been recently reported that PKA is a major regulator
of the physical and functional association between
MAPK and their inactivating protein tyrosine phos-
phatases (PTP). Upon PKA activation, the associa-
tion of PTP with MAPK is impaired, and MAPK
tyrosine phosphorylation and nuclear translocation
is favored [44].
The function of the cAMP and Ca2 signaling
systems are intimately linked. Nine adenylyl cyclase
isoforms have been cloned and all nine isoforms can
be regulated directly (AC I,III, VIII) or indirectly by
Ca2 [45]. One of the earliest PTH signals is an ele-
vation in intracellular Ca2. In this regard, as de-
scribed before we have recently found that PTH elic-
its a rapid IP3-mediated mobilization of Ca2 from a
thapsigargin-sensitive store and a sustained phase
due to Ca2 in£ux through voltage-dependent
Ca2-channels ([12,13]; G. Picotto, submitted). The
relationship of the rise in intracellular Ca2 by PTH
leading to MAPK activation is not de¢ned. There-
fore, in the present study, we also evaluated the par-
ticipation of Ca2 on MAPK activation. Our results
indicate that the Ca2 signal precedes the activation
of MAPK, consistent with a role for Ca2 as an
upstream activator of MAPK in enterocytes. A sim-
ilar degree of phosphorylation of MAPK was elicited
by the Ca2 mobilizing agent thapsigargin, the Ca2
ionophore A23187, ionomycin and membrane depo-
larization with high K. The suppression of PTH
response by BAPTA, EGTA, and to a lesser extent
by the L-type Ca2 channel blocker verapamil,
strongly suggests that the stimulatory e¡ect is speci¢c
for Ca2.
As in rat enterocytes PTH activates the non-recep-
tor tyrosine kinase c-Src, which, in turn, acts as one
of the signal transduction molecules linking up the
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signal of the hormone to the MAPK pathway [15],
the partial blockade of PTH-induced MAPK phos-
phorylation by c-AMP and Ca2 antagonists, indi-
cates that more than one signal contributes to PTH
action. Our results also reveal that the hormone does
not require the intermediary formation of the calci-
um^calmodulin (CAM) complex to activate the
MAPK cascade. Studies with isolated parathyroid
membranes have shown that Ca2, independently
of CAM, regulates adenylyl cyclase activity [46].
Therefore, it is possible that the adenylyl cyclase iso-
forms involved in PTH regulation of MAPK in en-
terocytes may be activated by Ca2 without the par-
ticipation of CAM. Despite the ¢nding that Ca2
may be acting independently of CAM, questions re-
main regarding how the Ca2 sensitivity of the ade-
nylyl cyclase(s) is achieved.
Variations in intracellular Ca2 have been shown
to be determinant in the regulation of the Ras/
MAPK pathway through mechanisms not completely
understood [47^49], although the involvement of
p21Ras, Raf and MEK has been suggested [50].
Thus, it has been demonstrated that an increase in
intracellular Ca2 directly or indirectly induces Shc
tyrosine phosphorylation, which in turn associates
with Grb2 and Sos, resulting in the activation of
p21Ras [51]. Furthermore, non-receptor tyrosine ki-
nases have been implicated between stimuli which
trigger calcium elevation and MAPK activation [52].
Taken together, our data indicate that Ca2 re-
lease from internal stores and Ca2 in£ux from the
external milieu, signi¢cantly contribute to PTH-in-
duced MAPK activation in rat enterocytes. How
PTH-induced increases in cytosolic Ca2 stimulate
tyrosine phosphorylation of MAPK is not known,
but they might involve as mentioned before activa-
tion of a Ca2-dependent isoform of adenylyl cyclase
[45], c-Src kinase activation [53,54], or Ca2-depen-
dent assembly of some component(s) upstream in-
volved in the activation of the MAPK pathway.
Although the mechanisms involved in extracellular
signal modulation of the MAP kinase cascade de-
pend on the types of agonists and target cells, our
results suggest that cAMP and Ca2 play a role up-
stream in the signaling pathway leading to MAPK
activation by PTH in rat intestinal cells.
Of physiological signi¢cance, in agreement with
the well-known participation of MAPK in pathways
leading to mitogenic e¡ects, the present study shows
that MAP kinase modulation through these messen-
ger systems mediates PTH stimulation of duodenal
cell proliferation, as evidenced by the fact that
PD098059, a speci¢c MEK inhibitor, blocked the
ability of the hormone to stimulate DNA synthesis.
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